by Anais MAX | Mar 29, 2022 | Press Releases
DOWNLOAD THE PRESS RELEASE (.PDF) SYNSIGHT, a biotech company specialized in RNA-targeting small molecules drugs, today announce a $1.5 million fundraising. The financing was led by an international investor. SYNSIGHT is pleased to announce today a $1.5 million...
by Anais MAX | Dec 23, 2021 | Press Releases
DOWNLOAD THE PRESS RELEASE (.PDF) Institut Imagine and SYNSIGHT are joining forces to develop research projects around innovative technological services in drug discovery. Institut Imagine and SYNSIGHT are joining their efforts and resources in joint research projects...
by Anais MAX | Dec 2, 2021 | Press Releases
READ FULL PR Online PR News – 30-November-2021 – SYNSIGHT has a unique high-content screening platform powered by deep learning to discover and develop novel drugs primarily for RNA targets. SYNSIGHT has chosen Mcule to manage compound sourcing, storage,...
by Anais MAX | Nov 29, 2021 | Press Releases
DOWNLOAD THE PRESS RELEASE (.PDF) BIOCUBATE, a chinese base biotechnology company specializing in business development and incubation of bio-innovative projects, and SYNSIGHT, a french drug discovery company based on single-cell imaging and artificial intelligence...